Kepricet

Levetiracetam, the active ingredient in Kepricet, is a Antiepileptic presented as an oral dosage form for Oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Kepricet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kepricet, an antiepileptic drug, is employed in the management of seizure disorders. - Epilepsy: reduces the frequency and severity of seizures across the epilepsy spectrum. - Partial seizures: controls focal onset seizures that originate in a specific brain region. - Generalized seizures: helps prevent tonic‑clonic and other generalized seizure types.

Levetiracetam may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or lacking energy. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Depression or suicidal thoughts: mood disturbances requiring immediate attention. - Blood disorders: including leukopenia or thrombocytopenia. - Multi‑organ hypersensitivity: systemic allergic response. - Severe allergic reactions: anaphylaxis or angioedema. - Hepatic injury: rare liver function abnormalities.

When prescribing or dispensing Kepricet, several safety considerations should be observed. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Pregnancy: potential risks are unknown; use only if benefits outweigh risks. - Concomitant CNS depressants: may enhance sedation and impair coordination. - Driving or operating machinery: caution advised due to possible dizziness or drowsiness. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing levetiracetam levels. - Phenytoin: increases hepatic enzyme activity, lowering drug concentration. - Rifampin: strong enzyme inducer that may decrease therapeutic effect.

Moderate Interactions (Monitor Closely): - Valproic acid: may raise levetiracetam plasma levels. - Alcohol: can intensify central nervous system depression. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, requiring additional contraceptive measures.